CUBT
Price:
$0.009
Market Cap:
$8.13M
Curative Biotechnology, Inc. operates as a development-stage biomedical company. The company develops pipeline focusing on therapeutic areas, such as infectious diseases, oncology, and degenerative eye disease. Its pipeline candidates include IMT504, a novel immune therapy to treat rabies and an adjuvant for vaccines; CUBT906, a fully humanized CD56 monoclonal antibody carrying a pyrrolobenzodiazepine dimer directly to the tumor site to kill the tumor by inhibiting tumor growth and migration of the tumor; and Metformin Reformulation for the treatment of degenerative eye disease. The company has a licensing and co-development agreement with Mid-Atlantic BioTherapeutics, Inc. to develop IMT504...[Read more]
Industry
Biotechnology
IPO Date
1998-03-30
Stock Exchange
PNK
Ticker
CUBT
According to Curative Biotechnology, Inc.’s latest financial reports and current stock price. The company's current Enterprise Value is 10.29M. This represents a change of -42.84% compared to the average of 18.01M of the last 4 quarters.
The mean historical Enterprise Value of Curative Biotechnology, Inc. over the last ten years is 6.68M. The current 10.29M Enterprise Value has changed 15.31% with respect to the historical average. Over the past ten years (40 quarters), CUBT's Enterprise Value was at its highest in in the March 2024 quarter at 26.50M. The Enterprise Value was at its lowest in in the December 2021 quarter at -493350.84.
Average
6.68M
Median
701.60K
Minimum
230.90K
Maximum
25.38M
Discovering the peaks and valleys of Curative Biotechnology, Inc. Enterprise Value, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 1.31%
Maximum Annual Enterprise Value = 25.38M
Minimum Annual Increase = -61.14%
Minimum Annual Enterprise Value = 230.90K
Year | Enterprise Value | Change |
---|---|---|
2023 | 16.31M | 30.95% |
2022 | 12.45M | -50.94% |
2021 | 25.38M | 147.26% |
2020 | 10.26M | 1.31% |
2019 | 726.43K | 214.41% |
2018 | 231.05K | 0.06% |
2017 | 230.90K | -12.22% |
2016 | 263.03K | -61.14% |
2015 | 676.78K | 174.38% |
2014 | 246.66K | -4.05% |
The current Enterprise Value of Curative Biotechnology, Inc. (CUBT) is less than than its 3-year, less than than its 5-year, and greater than its 10-year historical averages
3-year avg
18.05M
5-year avg
13.03M
10-year avg
6.68M
Curative Biotechnology, Inc.’s Enterprise Value is less than Biotron Limited (19.38M), less than Bioasis Technologies Inc. (39.49M), less than Covalon Technologies Ltd. (85.64M), greater than Mosaic ImmunoEngineering Inc. (6.48M), less than Ceapro Inc. (15.88M), less than Cellectis S.A. (144.28M), less than Resverlogix Corp. (17.80M), less than Small Pharma Inc. (39.47M),
Company | Enterprise Value | Market cap |
---|---|---|
19.38M | $13.08M | |
39.49M | $28.44M | |
85.64M | $67.67M | |
6.48M | $5.43M | |
15.88M | $13.31M | |
144.28M | $183.12M | |
17.80M | $11.12M | |
39.47M | $37.51M |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Curative Biotechnology, Inc. using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like Curative Biotechnology, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the Enterprise Value?
How can you use the Enterprise Value?
What is Curative Biotechnology, Inc.'s Enterprise Value?
What is the highest Enterprise Value for Curative Biotechnology, Inc. (CUBT)?
What is the 3-year average Enterprise Value for Curative Biotechnology, Inc. (CUBT)?
What is the 5-year average Enterprise Value for Curative Biotechnology, Inc. (CUBT)?
How does the current Enterprise Value for Curative Biotechnology, Inc. (CUBT) compare to its historical average?